Roche Signs Definitive Merger Agreement with GenMark Diagnostics
“Acquiring GenMark Diagnostics will broaden our molecular diagnostics portfolio to include solutions that can provide lifesaving information quickly to patients and their healthcare providers in the fight against infectious diseases,” says Thomas Schinecker, CEO Roche Diagnostics.
Read More